Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of this study is to assess the feasibility of conducting a large hospital based case control study of the role of dioxins and dioxinlike polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 79 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients with Soft Tissue Sarcoma at Memorial Sloan Kettering Cancer Center.
Patients with Soft tissue sarcoma at MSKCC are eligible for this study if they meet the following criteria:
Between 18 and 79 years of age
were diagnosed within the previous 6 months with primary soft tissue sarcoma of one of the following histologic subtypes: liposarcoma, leiomyoscaroma, MFH, or synovial sarcoma
are enrolled in protocol 02-060 ("Novel Biochemical and Molecularr Determinants for Soft Tissue Sarcoma"; PI, Dr. Samuel Singer)
controls will be eligibile for this study if they meet the following criteria
are b/w 18-79 years of age
have no prior history of cancer (other than non melanoma skin cancer)
Individuals will be excluded if they
are unable to sign informed consent for medical or other reasons